Skip to main content

Table 3 Intention to treat analysis of enrolled study subjects

From: Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial

 

Completion of the study

 Baseline (n = 87)

Normal echogenic response

Fatty liver

Tocotrienols (n = 43)

15/43

28/43

 

34.9%

65.1%

Placebo (n = 44)

8/44

36/44

 

18.2%

81.8%

Tocotrienols vs Placebo

P = 0.038

 
  1. Drop-out subjects were computed as having an unchanged diagnosis of fatty liver from baseline.
  2. [Helmert-Pearson’s Chi Square; Numbers’09, GraphPad].
Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us